Literature DB >> 11167645

The information required by patients with early-stage prostate cancer in choosing their treatment.

D Feldman-Stewart1, M D Brundage, J C Nickel, W J MacKillop.   

Abstract

OBJECTIVE: To determine the information that men diagnosed with early-stage prostate cancer think is necessary to choose their treatment (surgery, radiotherapy or 'watchful waiting'). PATIENTS AND METHODS: All men diagnosed with early-stage prostate cancer in a regional urology practice in an 18-month period were surveyed. Respondents considered the treatment decision for a specific hypothetical case and judged whether each of 59 specific information items would be 'necessary' to know to make the treatment decision. Respondents provided basic demographic information (age, education and marital status).
RESULTS: Of 89 patients, 71 (80%) responded; the mean (SD, range) number of items that individual respondents identified as necessary was 32 (12, 9-58). Each item was considered necessary by 54 (18, 20-93)% of respondents. Of the 59 items, only five were necessary to > or = 80% of respondents; 23 were necessary to > or = 67% of respondents and five were not necessary to > or = 67% of respondents. Patients were divided about the remaining 31 items. There were no strong correlations (none accounted for > 20% of the variance) between the responses and demographic characteristics.
CONCLUSIONS: There appears to be large variation among patients with early-stage prostate cancer in the number of information items deemed necessary to make a treatment decision, and little agreement on the need for most individual items. Demographic characteristics were not useful as predictors of the information needs of each patient. The process of informing patients with early-stage prostate cancer (and their decision aids) needs to be flexible and able to accommodate a wide range of patients' information needs.

Entities:  

Mesh:

Year:  2001        PMID: 11167645     DOI: 10.1046/j.1464-410x.2001.02046.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  15 in total

1.  Evidence-based patient choice: a prostate cancer decision aid in plain language.

Authors:  Margaret Holmes-Rovner; Sue Stableford; Angela Fagerlin; John T Wei; Rodney L Dunn; Janet Ohene-Frempong; Karen Kelly-Blake; David R Rovner
Journal:  BMC Med Inform Decis Mak       Date:  2005-06-20       Impact factor: 2.796

2.  What are pregnant women's information needs and information seeking behaviors prior to their prenatal genetic counseling?

Authors:  Yichuan Hsieh; Patricia Flatley Brennan
Journal:  AMIA Annu Symp Proc       Date:  2005

3.  Association of Preexisting Symptoms with Treatment Decisions among Newly Diagnosed Prostate Cancer Patients.

Authors:  Steven B Zeliadt; Scott D Ramsey; Arnold L Potosky; Neeraj K Arora; David K Blough; Ingrid Oakley-Girvan; Ann S Hamilton; Stephen K Van Den Eeden; David F Penson
Journal:  Patient       Date:  2008-07-01       Impact factor: 3.883

4.  Helping patients with localized prostate cancer reach treatment decisions.

Authors:  Kathryn Birnie; John Robinson
Journal:  Can Fam Physician       Date:  2010-02       Impact factor: 3.275

Review 5.  A systematic review of information in decision aids.

Authors:  Deb Feldman-Stewart; Sarah Brennenstuhl; Kathryn McIssac; Joan Austoker; Agathe Charvet; Paul Hewitson; Karen R Sepucha; Tim Whelan
Journal:  Health Expect       Date:  2007-03       Impact factor: 3.377

6.  The influence of distress on knowledge transfer for men newly diagnosed with prostate cancer.

Authors:  R B Hovey; K E S Cuthbertson; K A Birnie; J W Robinson; B C Thomas; H F Massfeller; J D Ruether; C Scott
Journal:  J Cancer Educ       Date:  2012-06       Impact factor: 2.037

7.  A decision aid for men with early stage prostate cancer: theoretical basis and a test by surrogate patients.

Authors:  D Feldman-Stewart; M D Brundage; L Van Manen
Journal:  Health Expect       Date:  2001-12       Impact factor: 3.377

8.  Patient-focussed decision-making in early-stage prostate cancer: insights from a cognitively based decision aid.

Authors:  Deb Feldman-Stewart; Michael D Brundage; Lori Van Manen; Ola Svenson
Journal:  Health Expect       Date:  2004-06       Impact factor: 3.377

9.  "It's not like I can change my mind later": reversibility and decision timing in prostate cancer treatment decision-making.

Authors:  Nora B Henrikson; William J Ellis; Donna L Berry
Journal:  Patient Educ Couns       Date:  2009-04-21

10.  Cancer patients' preferences for communicating clinical trial quality of life information: a qualitative study.

Authors:  M Brundage; A Leis; A Bezjak; D Feldman-Stewart; L Degner; K Velji; L Zetes-Zanatta; D Tu; P Ritvo; J Pater
Journal:  Qual Life Res       Date:  2003-06       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.